Alterity Therapeutics (PRNAD) Return on Equity (2018 - 2019)
Alterity Therapeutics (PRNAD) posted quarterly Return on Equity of 0.02% for Q2 2019, down 4.98% on a QoQ basis from 0.02% in Q4 2018.
Alterity Therapeutics (PRNAD) Return on Equity (2018 - 2019) Analysis & Trends
Alterity Therapeutics (PRNAD) has reported Return on Equity for 2 consecutive years, with 0.02% the latest figure, recorded in Q2 2019.
- In Q2 2019, Return on Equity changed N/A year-over-year to 0.02%; the TTM figure through Jun 2019 stood at 0.02% (changed N/A YoY), while the FY2023 annual figure was 6438.94%, down 643893.0% from the prior year.
- Return on Equity came in at 0.02% for Q2 2019 at Alterity Therapeutics, down from 0.02% in the prior quarter.
- The five-year high for Return on Equity was 0.02% in Q4 2018, with the low at 0.02% in Q2 2019.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -0.02% |
| Dec 31, 2018 | -0.02% |